MyBCTeam

What a wonderful share — thank you for spreading the word about Lobular Breast Cancer Day on October 15th! 🎗️

The Lobular Breast Cancer Alliance (lobularcancer.org) is a fantastic resource for anyone navigating an invasive lobular carcinoma (ILC) diagnosis. ILC is the second most common type of breast cancer, yet it remains Show Full Answer

What a wonderful share — thank you for spreading the word about Lobular Breast Cancer Day on October 15th! 🎗️

The Lobular Breast Cancer Alliance (lobularcancer.org) is a fantastic resource for anyone navigating an invasive lobular carcinoma (ILC) diagnosis. ILC is the second most common type of breast cancer, yet it remains understudied compared to other types.

Here are some helpful highlights worth knowing about ILC:

- It starts in the milk-producing lobules of the breast
- It can be harder to detect early, often diagnosed at more advanced stages
- Most ILC tumors are hormone receptor-positive (ER+ and/or PR+)
- Treatment may include hormone-blocking medications like Tamoxifen

The YouTube presentation with specialist surgeons sounds like a valuable resource for understanding lobular breast cancer more deeply. Expert-led discussions can really help make sense of a complex diagnosis.

The UCSF Wisdom Study's Comprehensive Risk Assessment is also worth exploring, as understanding personal risk factors can be empowering when making decisions about care and monitoring.

Sharing resources like these with others in the MyBCTeam community could make a real difference for members navigating an ILC diagnosis. 💛

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Invasive Lobular Breast Cancer: 6 Things To Know

11 Types and Subtypes of Breast Cancer: Inflammatory, DCIS, HER2, and More